Ann Costello
Vermogen: 45 642 $ op 31-07-2026
Vermogen: 45 642 $ op 31-07-2026
Ann Costello is currently an Independent Director at Elekta AB since 2024, a Director at Ibex Medical Analytics Ltd., and an Independent Director at Freenome, Inc. starting in 2026.
Formerly, Ms. Costello was Head of Diagnostics Solutions Business at Roche Group from 2020 to 2023.
Education includes an undergraduate degree from Technological University Dublin.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-04-2026 | 9.000 ( 0% ) | 45 642 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ELEKTA AB | Directeur/Bestuurslid | 01-09-2024 |
Ibex Medical Analytics Ltd.
Ibex Medical Analytics Ltd. Packaged SoftwareTechnology Services Develops and operates medical analysis platform for pathology and cancer diagnostics | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | 02-01-2023 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Elekta AB
Elekta AB Medical SpecialtiesHealth Technology Manufactures radiation oncology and neurosurgery instruments | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
Ibex Medical Analytics Ltd.
Ibex Medical Analytics Ltd. Packaged SoftwareTechnology Services Develops and operates medical analysis platform for pathology and cancer diagnostics | Technology Services |
Technological University Dublin
Technological University Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau